FDA notifications. Generic lopinavir/ritonavir approved by FDA.
D017277:Drug Approval / Q000331:legislation & jurisprudence*; D004338:Drug Combinations; D016568:Drugs, Generic / Q000008:administration & dosage* / Q000627:therapeutic use; D017320:HIV Protease Inhibitors / Q000008:administration & dosage* / Q000627:therapeutic use; D006801:Humans; D061466:Lopinavir; D011744:Pyrimidinones / Q000008:administration & dosage* / Q000627:therapeutic use; D019438:Ritonavir / Q000008:administration & dosage* / Q000627:therapeutic use; D014481:United States; D014486:United States Food and Drug Administration
D004338:Drug Combinations; D016568:Drugs, Generic; D017320:HIV Protease Inhibitors; D011744:Pyrimidinones; D061466:Lopinavir; D019438:Ritonavir